Medicare at 50 Act
- Last Action
- 4/21/2021
Actions
- 2021-04-21Read twice and referred to the Committee on Finance.
- 2021-04-21Introduced in Senate
CRS Summary
As of 2021-04-21 (00)
Medicare at 50 Act
This bill establishes a Medicare buy-in option for certain qualifying individuals and also repeals restrictions relating to prescription drug prices under the Medicare prescription drug benefit.
Specifically, the bill allows individuals aged 50 to 64 to enroll in Medicare if such individuals would otherwise qualify for Medicare at the age of 65. The Centers for Medicare & Medicaid Services (CMS) must determine enrollment periods and set premiums for the buy-in option established under the bill, in accordance with specified requirements. The CMS must also award grants to states and nonprofit organizations for outreach and enrollment activities relating to the buy-in option.
The bill also repeals provisions that prohibit the CMS from negotiating the prices of prescription drugs or from establishing a formulary under the Medicare prescription drug benefit.
Cosponsors (19)
- Sherrod Brown (D-OH)
- Tammy Baldwin (D-WI)
- Richard Blumenthal (D-CT)
- Ben Cardin (D-MD)
- Bob Casey (D-PA)
- Tammy Duckworth (D-IL)
- Richard Durbin (D-IL)
- Kirsten Gillibrand (D-NY)
- Amy Klobuchar (D-MN)
- Edward Markey (D-MA)
- Jeff Merkley (D-OR)
- Gary Peters (D-MI)
- John Reed (D-RI)
- Jeanne Shaheen (D-NH)
- Tina Smith (D-MN)
- Chris Van Hollen (D-MD)
- Sheldon Whitehouse (D-RI)
- Cory Booker (D-NJ)
- Patrick Leahy (D-VT)
Subjects
- Advisory bodies
- Government trust funds
- Health care costs and insurance
- Health care coverage and access
- Inflation and prices
- Medicaid
- Medicare
- Prescription drugs
- Public contracts and procurement
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.